LEIDEN JEFFREY M (Executive Chairman) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000875320-26-000092
DirectorOfficer· Executive Chairman
Since Feb 2026
+5.30K
Net shares
Net buyer
$1.43M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
8.27K acquired · 2.96K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.27K
Price / share
—
Trade value
—
% of position
25.0%
2/17/2026
33.04K→41.31K
Common Stock
Direct
Shares
−2.96K
Price / share
$483.75
Trade value
$1.43M
% of position
7.2%
2/18/2026
41.31K→38.34K
Total
Net shares
+5.30K
Net value
-$1.43M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +8.27K | — | — | 25.0% | 33.04K | 41.31K |
| Common Stock Direct | 2/18/2026 | F · Tax Withholding | −2.96K | $483.75 | $1.43M | 7.2% | 41.31K | 38.34K |
| Total | +5.30K | -$1.43M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned440.00
Total
440.00 indirect440.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 440.00 | Indirect |
| Total | 440.00 | 440.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported